Imagenetix, Inc. (IAGX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Jul 18, 2025
Accolade Revenue
Imagenetix had revenue of $377.52K in the quarter ending June 30, 2015, a decrease of -30.75%.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
29.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2015 | - | - | - |
| Mar 31, 2011 | 7.13M | 532.78K | 8.08% |
| Mar 31, 2010 | 6.60M | -864.80K | -11.59% |
| Mar 31, 2009 | 7.46M | 1.89M | 33.96% |
| Mar 31, 2008 | 5.57M | -27.13K | -0.48% |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |